Capsid

Novel Gene Therapy Vehicle Successfully Crosses Blood-Brain Barrier in Mice

Researchers at the Broad Institute have developed a groundbreaking gene therapy delivery vehicle that effectively crosses the blood-brain barrier in mice, offering new possibilities for treating a range of brain diseases. This innovative approach utilizes a human protein to transport therapeutic genes into the brain, promising safer and more efficient treatments for neurodevelopmental and neurodegenerative disorders.